323008 SE Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 (2023S)

(2 Courses)

5.00 ECTS (1.00 SWS), SPL 32 - Pharmazie

Continuous assessment of course work

Moodle

Details

Language: English

Lecturers

Classes (iCal) - next class is marked with N

Dates that are missing above (See Moodle for the schedule for each case study):
1st day of the course: Tuesday 02.05.2023 09.00-11.00 Web-based - all Case Studies
Wednesday 03.05.2023 16.00 - 18.00 Web-based (Case Study 1)
Friday 05.05.2023 14.00 - 16.00 Web-based (Case Study 3)
Monday 15.05.2023 13.00 - 15.00 Web-based (Case Study 3)
Thursday 18.05.2023 16.00 - 18.00 Web-based (Case Study 1)

    
    Friday
    05.05.
    09:00 - 11:00
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Tuesday
    16.05.
    09:00 - 11:00
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Wednesday
    31.05.
    09:00 - 11:30
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Monday
    05.06.
    14:00 - 16:30
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Tuesday
    06.06.
    15:00 - 17:30
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II

Information

Aims, contents and method of the course

Students will work in small teams on case studies to conceptualise concrete drug development project proposals, discuss the case study topics and revise their proposals with the supervisors. The case study will involve a real project conducted in industry. The outcomes from the industry research project will be revealed in the final lecture. The course will consist of Introduction to the course, two lectures, 3 assignments, and 3 feedback/discussion teaching sessions.

Assessment and permitted materials

Students must attend all sessions and actively participate in the discussion, complete and submit all of the assignments. They are expected to incorporate feedback and discussion outcomes into their revised final project proposal due before the last day of class.

Minimum requirements and assessment criteria

Enrollment in the Master of Drug Discovery and Development program. Successful completion of MPS1 in the Master of Drug Discovery and Development program. Course attendance; completion of assignments including revisions from feedback sessions to be submitted to instructors for evaluation. Final presentation to be submitted and given on last day of course and final revised proposal to be submitted to instructors.

Examination topics

Team presentation of the finalized project proposal (each team member must present)
Submission of the finalized research proposal and presentation slide deck.

Reading list

To be given in class

Association in the course directory

MPS7 Case Studies in Drug Discovery und Preclinical Drug Development (5 ECTS)

Master Drug Discovery and Development (606)

Last modified: Th 26.01.2023 11:50